Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Saphenous Nerve Block for Foot and Ankle Surgery: Complete Statistical AnalysisIndependent statistical analysis of Saphenous Nerve Block for Foot and Ankle Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02382744).
- SAPPHIREIndependent statistical analysis of Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SAPPHIREIndependent statistical analysis of Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03001414).
- Saracatinib in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267266).
- Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: Complete Statistical AnalysisIndependent statistical analysis of SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SARCAIndependent statistical analysis of Lansoprazole to Treat Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442013).
- SARONAPLUSIndependent statistical analysis of Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARS-CoV-2 Human Challenge Characterisation Study: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2 Human Challenge Characterisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04865237).
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631705).
- SASHIndependent statistical analysis of Poor Sleep and Inflammation in HIV-Infected Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03848325).
- SAT1Independent statistical analysis of University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SATISFACTIONIndependent statistical analysis of Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: Complete Statistical AnalysisIndependent statistical analysis of Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240200).
- Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence: Complete Statistical AnalysisIndependent statistical analysis of Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747850).
- SatraGO-2Independent statistical analysis of A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Savella in Treatment for Provoked Vestibulodynia: Complete Statistical AnalysisIndependent statistical analysis of Savella in Treatment for Provoked Vestibulodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304589).
- Savolitinib vs. Sunitinib in MET-driven PRCC.: Complete Statistical AnalysisIndependent statistical analysis of Savolitinib vs. Sunitinib in MET-driven PRCC.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03091192).
- SayWhenIndependent statistical analysis of Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SBIndependent statistical analysis of An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBATIndependent statistical analysis of School-based Asthma Therapy: Stage 2 Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01175369).
- SBRTvsTACEIndependent statistical analysis of Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- SCD PED-02Independent statistical analysis of A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCD-PED-01Independent statistical analysis of Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SCENT2Independent statistical analysis of Smell in Covid-19 and Efficacy of Nasal Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789499).
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): Complete Statistical AnalysisIndependent statistical analysis of SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): primary endpoint results, effect estimate with confidence interval,…
- SCHEARLYIndependent statistical analysis of A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: primary endpoint…
- School-Based Mental Health Effectiveness Study: Complete Statistical AnalysisIndependent statistical analysis of School-Based Mental Health Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04383327).
- SCIALEROIndependent statistical analysis of Regional Anesthesia for Major Surgery of the Foot. Levobupivacaïne Ropivacaine 0.5% Versus 0.5% in the Sciatic Block Through médiofémorale: primary endpoint results, effect estimate with confidence interval, sample-size…
- SCITMOIndependent statistical analysis of Subcutaneous Immunotherapy for Mouse in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532179).
- SclerodermaIndependent statistical analysis of Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530996).
- SCOBA-PHIndependent statistical analysis of Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330108).
- SCOPE-BDIndependent statistical analysis of Scopolamine in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04211961).
- SCOREIndependent statistical analysis of Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCOREDIndependent statistical analysis of Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk: primary endpoint results, effect estimate…
- Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: Complete Statistical AnalysisIndependent statistical analysis of Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCOTIndependent statistical analysis of Scleroderma: Cyclophosphamide or Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114530).
- SCOUTSIndependent statistical analysis of Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCRATCH-ADIndependent statistical analysis of The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval,…
- Screening and Brief Advice to Reduce Teen Substance Use: Complete Statistical AnalysisIndependent statistical analysis of Screening and Brief Advice to Reduce Teen Substance Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00227877).
- SCT&DVTIndependent statistical analysis of Sickle Cell Trait and the Risk of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01148940).
- Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).
- SDM-LCS-SCIndependent statistical analysis of Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SEAGUL2Independent statistical analysis of Study EvAluating Genotypes While Using Lucentis 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01464723).
- SEAIRAIndependent statistical analysis of Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SEALIndependent statistical analysis of Use of Tachosil® for Lymph Sealing During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01920958).